Adefovir dipivoxil-induced acute tubular necrosis and Fanconi syndrome in a renal transplant patient

AIDS

Volumn 23, Issue 4, 2009, Pages 544-545

  Izzedine, Hassane ^a   Kheder Elfekih, Rania ^a   Housset, Pierre ^a   Sarkozy, Clementine ^a   Brocheriou, Isabelle ^a   Deray, Gilbert ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LAMIVUDINE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADULT; BONE DENSITOMETRY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG WITHDRAWAL; FANCONI RENOTUBULAR SYNDROME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LABORATORY TEST; LETTER; LIVER FUNCTION TEST; MALE; NEPHROTOXICITY; OSTEOPOROSIS; PRIORITY JOURNAL;

ADENINE; ANTIVIRAL AGENTS; FANCONI SYNDROME; HEPATITIS B, CHRONIC; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHONIC ACIDS;

EID: 62349114930     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832407f7     Document Type: Letter

References (9)

1. Gane E, Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002; 74:427-437.
2. Peters MC, Singer G, Howard T, Jacobsmeyer S, Xiong X, Gibbs CS, et al. Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient. Transplantation 1999; 68:1912-1914.
3. Tillmann HL, BockCT, Bleck JS, Rosenau J, Böker KH, Barg-Hock H, et al. Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in patient whit cirrhosis and renal insufficiency. Liver Transplant 2003; 9:191-196.
4. Gallant J, Naeger L, Beal J, Myers R, Peterson D, Bruce J, et al. Adefovir dipivoxil (ADV) 60 mg and 120 mg in combination regimens for Pi-naive patients [abstract #528]. In: 7th Conference on Retroviruses and Opportunistic Infections; 30 January-2 February 2000; San Francisco, CA. p. 175.
5. Kahn J, Lagakos S, Wulfsohn M, Cherng D, Miller M, Cherrington J, et al. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy. A randomized, controlled trial. JAMA 1999; 282:2305-2312.
6. Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiftman ML, et al., Adefovir Dipivoxil 437 Study Group. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003; 348:808-816.
7. Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, et al., Adefovir Dipivoxil 438 Study Group. Longterm therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med 2005; 352:2673-2681.
8. Izzedine H, Hulot JS, Launay-Vacher V, Marcellini P, Hadziyannis SJ, Currie G, et al., Adefovir Dipivoxil International 437 Study Group, Adefovir Dipivoxil International 438 Study Group. Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int 2004; 66:1153-1158.
9. Lee HJ, Choi JW, Kim TN, Eun JR. A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus. Korean J Hepatol 2008; 14:381-386.